Business and development

  • The Pharmacy Business Unit was established in 1993. The unit undertakes special projects that will enhance paediatric health care. This may include the development of specialised drug products or publications. The unit is self-funding and any profits raised are directed into new projects, as well as equipment and education for the pharmacy department staff.


    The RCH Pharmacy Business Unit currently manage four products.  These products are:

    • Monosodium L-aspartate (MSA) 14 mmol/10 mL vials (supplied under Schedule 5A of the Therapeutic Goods Regulations 1990)
    • Nappy Goo Nappy Rash Cream 
    • HyperSal6, Sodium Chloride 6% 10mL sachets, Box of 150 (ARTG No. 275201)
    • Paediatric Injectable Guidelines - the RCH Paediatric Injectable Guidelines medication administration reference, available in both hard copy and online subscription


    Ph: 03 9345 5995